SCHEDULE: Great Point Partners Reports 2.44% Stake in Context Therapeutics

Great Point Partners, LLC, along with Dr. Jeffrey R. Jay, M.D. and Ms. Lillian Nordahl, has reported beneficial ownership of 2,238,496 shares, representing 2.44% of Context Therapeutics Inc.'s common stock as of March 31, 2026.

Summary

• Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl have jointly filed a Schedule 13G/A, indicating their beneficial ownership of Context Therapeutics Inc. common stock.
• The reporting persons collectively own 2,238,496 shares, which constitutes 2.44% of the total outstanding common stock.
• This ownership level is below the 5% threshold that typically triggers more detailed reporting requirements.
• The filing is an amendment (Amendment No. 7) to a previous filing, with the event date requiring this statement being March 31, 2026.
• The reporting persons have entered into a Joint Filing Agreement to file this statement jointly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing. It's a routine disclosure of a passive ownership stake below the 5% threshold, providing factual information without indicating significant positive or negative developments for the company.

Positives

• The reporting persons collectively hold a significant minority stake, indicating a level of investment interest in Context Therapeutics Inc.
• The filing is up-to-date as of March 31, 2026, providing current ownership information.

Negatives

• The ownership stake of 2.44% is below the 5% threshold, suggesting the reporting persons do not hold a controlling or significantly influential position in the company.

Risks

• The filing does not explicitly mention any risks. However, as a Schedule 13G filing, it primarily reports ownership stakes and does not typically detail operational or market risks.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The reporting persons have entered into a Joint Filing Agreement, dated May 15, 2026, pursuant to which they have agreed to file this statement jointly.
• Each reporting person certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment firms to report passive ownership stakes in publicly traded companies. Great Point Partners, LLC is a known investment firm, and their filing indicates a passive investment in Context Therapeutics Inc., which operates in the biotechnology sector.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant ownership stakes, which can be relevant for understanding the company's investor base.
• Management: The filing confirms that the reporting persons do not intend to influence or control the company's management, as per their certification.

Next Steps

• The reporting persons will continue to monitor their investment in Context Therapeutics Inc.
• Future amendments to this filing will be made if ownership levels change significantly.

Key Dates

Keywords

Context Therapeutics Inc., Schedule 13G, Great Point Partners, ownership, beneficial ownership, common stock, SEC filing, investment